Mainz Biomed B.V. Statistics
Share Statistics
Mainz Biomed B.V. has 3.04M
shares outstanding. The number of shares has increased by -89.85%
in one year.
| Shares Outstanding | 3.04M |
| Shares Change (YoY) | -89.85% |
| Shares Change (QoQ) | 10.94% |
| Owned by Institutions (%) | 1.03% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5,856 |
| FTD / Avg. Volume | 2.35% |
Short Selling Information
The latest short interest is 69.42K, so 3.13% of the outstanding
shares have been sold short.
| Short Interest | 69.42K |
| Short % of Shares Out | 3.13% |
| Short % of Float | 3.25% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.19 and the forward
PE ratio is -1.49.
Mainz Biomed B.V.'s PEG ratio is
0.
| PE Ratio | -0.19 |
| Forward PE | -1.49 |
| PS Ratio | 4.68 |
| Forward PS | 0.2 |
| PB Ratio | 0.69 |
| P/FCF Ratio | -0.24 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Mainz Biomed B.V..
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.32,
with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.32 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | -0.17 |
| Debt / FCF | -0.19 |
| Interest Coverage | -17.39 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $47,052.16 |
| Profits Per Employee | $-1,139,508.58 |
| Employee Count | 19 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 0.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -92.29% in the
last 52 weeks. The beta is 0.51, so Mainz Biomed B.V.'s
price volatility has been higher than the market average.
| Beta | 0.51 |
| 52-Week Price Change | -92.29% |
| 50-Day Moving Average | 3.97 |
| 200-Day Moving Average | 8.15 |
| Relative Strength Index (RSI) | 31.45 |
| Average Volume (20 Days) | 249,205 |
Income Statement
In the last 12 months, Mainz Biomed B.V. had revenue of 893.99K
and earned -21.65M
in profits. Earnings per share was -22.36.
| Revenue | 893.99K |
| Gross Profit | 574.88K |
| Operating Income | -18.7M |
| Net Income | -21.65M |
| EBITDA | -19.56M |
| EBIT | -20.58M |
| Earnings Per Share (EPS) | -22.36 |
Full Income StatementBalance Sheet
The company has 6.24M in cash and 3.27M in
debt, giving a net cash position of 2.96M.
| Cash & Cash Equivalents | 6.24M |
| Total Debt | 3.27M |
| Net Cash | 2.96M |
| Retained Earnings | -90.98M |
| Total Assets | 13.24M |
| Working Capital | 1.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -17.09M
and capital expenditures -254.95K, giving a free cash flow of -17.34M.
| Operating Cash Flow | -17.09M |
| Capital Expenditures | -254.95K |
| Free Cash Flow | -17.34M |
| FCF Per Share | -17.91 |
Full Cash Flow StatementMargins
Gross margin is 64.31%, with operating and profit margins of -2091.23% and -2421.8%.
| Gross Margin | 64.31% |
| Operating Margin | -2091.23% |
| Pretax Margin | -2421.8% |
| Profit Margin | -2421.8% |
| EBITDA Margin | -2187.76% |
| EBIT Margin | -2091.23% |
| FCF Margin | -1940.17% |
